TCOV
SYNH

Trust Company of Vermont’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Trust Company of Vermont’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-191
Closed -$6.8K – 915
2023
Q1 		$6.8K Hold
191
– – ﹤0.01% 751
2022
Q4 		$7.01K Hold
191
– – ﹤0.01% 738
2022
Q3 		$9K Hold
191
– – ﹤0.01% 743
2022
Q2 		$14K Buy
+191
New +$14K ﹤0.01% 632

Other funds holding SYNH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Trust Company of Vermont's SYNH Position: Q2 2023 in Review

Trust Company of Vermont sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 191 shares — an estimated $6.8K sold.

Trust Company of Vermont first reported a position in SYNH in Q2 2022 and held it in 4 quarters. The position peaked at $14K in Q2 2022. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • Trust Company of Vermont reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Trust Company of Vermont sold 191 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $6.8K.
  • Trust Company of Vermont first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2022 and held it in 4 quarters.
  • Trust Company of Vermont's Syneos Health, Inc. Class A Common Stock position peaked at $14K in Q2 2022.
  • 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Trust Company of Vermont's 13F filing for Q2 2023, filed 17 Jul 2023.